Savvy Updates, 7/11/22: Vertex Resumes Testing, US Senate Dems Move to Lower Drug Prices, Potatoes Better with Vinegar, Sugar Cravings Reduce by New Gum
Vertex, continuing its rebound, cleared to resume testing of diabetes cell therapy was written by Ben Fidler for BioPharmaDive.com, 6 July 2022. The Food and Drug Administration has cleared Vertex Pharmaceuticals to resume a study evaluating an...
Savvy Updates, 7/5/22: Call for Advocacy: FDA re CGM Access to Data & Cybersecurity, How Immune Cells Learn, POGO BG Meter, Sleep Quality & T1D
The ENTIRE Diabetes Community needs you to take action. The US FDA held a webinar on Cybersecurity in Medical Devices in June 2022, asking for feedback and comments, accepted through 7 July 2022. Time is of the ESSENCE! At issue: Unlimited,...
Savvy Updates 6/27/22: 4/5 of US PWDs in Debt for Medical Costs/Insulin, Hydration Affects BG Levels
4 Out Of 5 Americans With Diabetes Went Into Debt To Pay For Insulin was contributed by Deb Gordon for Forbes.com, 20 June 2022. According to a new study, released in earliy June from CharityRx, 79% of U.S. adults who have diabetes or care for someone who does...
Savvy Hot News, 6/17/22: FTC votes unanimously to increase scrutiny over PBMs ~ FOCUS on INSULIN!
FTC votes unanimously to increase scrutiny over pharmacy agent fees was reported by Dulan Lokuwithana for SeekingAlpha.com, 16 June 2022. The Federal Trade Commission (FTC) voted unanimously to adopt a policy statement stating its intention to more closely examine the...
More Diabetes Blogs